Wakefulness-promoting agent (Schedule IV)

Nuvigil (armodafinil) Withdrawal

Nuvigil (armodafinil) is the R-enantiomer of modafinil and a Schedule IV agent with low dependence potential. For most patients, stopping mainly returns sleepiness and fatigue. Importantly, though, the armodafinil FDA label cites postmarketing reports of withdrawal symptoms after abrupt cessation or dose reduction following chronic use - so it is not entirely benign, and a taper is prudent after long-term use.

By Dr. Ben Soffer, DO — board-certified physician, at-home ketamine therapy in Florida and New Jersey.

Half-life

~15 hours. Armodafinil is the longer-lasting R-enantiomer of modafinil.

Withdrawal timeline

Onset— Days 1-2

Daytime sleepiness returns as levels fall.

Peak— Days 2-5

Fatigue and low energy are most noticeable; after chronic use, the rarer withdrawal symptoms below can appear.

Resolution— 1-2 weeks

Alertness re-baselines within a couple of weeks; the underlying condition persists.

Common symptoms

  • Daytime sleepiness
  • Fatigue
  • Low energy
  • Difficulty concentrating

Less common

  • Low mood
  • Irritability
  • Headache

Notable / pattern-defining symptoms

Postmarketing withdrawal reports - the armodafinil label notes that abrupt cessation or dose reduction after chronic use has been associated with shaking, sweating, chills, nausea, confusion, and (rarely) withdrawal seizures. These are uncommon, but they are the reason to taper after long-term use rather than stop abruptly.

Tapering guidance

  • After short-term use, many patients can stop directly; after chronic or long-term use, taper gradually given the postmarketing withdrawal reports.
  • Coordinate with the prescribing physician.

Where ketamine therapy fits

Ketamine therapy does not treat armodafinil discontinuation. As with modafinil, it can be relevant when fatigue stems from an underlying depression. Coordinate with the prescribing physician.

Check ketamine therapy eligibilityMedication safety with ketamine

Frequently asked questions

Does Nuvigil cause withdrawal?

Dependence potential is low and for most patients stopping mainly returns sleepiness and fatigue. However, the FDA label cites postmarketing reports of withdrawal symptoms (shaking, sweating, nausea, and rarely seizures) after abrupt cessation of chronic use, so a taper is prudent after long-term use.

Is armodafinil different from modafinil when stopping?

They are similar and both are Schedule IV. Armodafinil lasts a bit longer, and its label carries somewhat more explicit postmarketing withdrawal reports, so erring toward a taper after long-term use is reasonable.

Can I combine Nuvigil with ketamine therapy?

Generally yes, with coordination. There is no required washout.

Important: This page is informational and does not constitute medical advice or a recommendation to start, stop, or change any medication. Tapering psychiatric medications should always be coordinated with the prescribing physician. Compounded ketamine for anxiety, depression, PTSD, and chronic pain is not FDA approved.

Browse all medication withdrawal guides.